Studies on the cross-clade and cross-species conservation of HIV-1 Gag-specific CD8 and CD4 T cell responses elicited by a clade B DNA/MVA vaccine in macaques

Virology

Volumn 334, Issue 1, 2005, Pages 124-133

  Amara, Rama Rao ^a,b   Sharma, Sunita ^a,b   Patel, Milloni ^a,b,c   Smith, James M ^a,b,d   Chennareddi, Lakshmi ^a,b   Herndon, James G ^b   Robinson, Harriet L ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cross clade activity; DNA MVA; HIV 1; T cell responses; Vaccine

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MODIFIED VACCINIA ANKARA VACINE; UNCLASSIFIED DRUG; VACCINIA VACCINE;

AMINO ACID SEQUENCE; ARTICLE; CLADISTICS; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS RECOMBINANT;

EID: 14644437662     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2005.01.026     Document Type: Article

References (49)

1. R.R. Amara, F. Villinger, J.D. Altman, S.L. Lydy, S.P. O'Neil, S. Staprans, D.C. Montefiori, Y. Xu, J.G. Herndon, L.S. Wyatt, M.A. Candido, N.L. Kozyr, P.L. Earl, J.M. Smith, H.-L. Ma, B.D. Grimm, M.L. Hulsey, J. Miller, H.M. McClure, J.M. McNicholl, B. Moss, and H.L. Robinson Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine Science 292 2001 69 74
2. R.R. Amara, J.M. Smith, S. Staprans, D. Montefiori, F. Villinger, J.D. Altman, S.P. O'Neil, N.L. Kozyr, Y. Xu, L. Wyatt, P.L. Earl, J.G. Herndon, J.M. McNicholl, H.M. McClure, B. Moss, and H.L. Robinson Critical role for Env as well as Gag-Pol for the control of a pathogenic SHIV challenge by a DNA/rMVA Vaccine J. Virol. 76 12 2002 6138 6146
3. R.R. Amara, F. Villinger, S. Staprans, J.D. Altman, D. Montefiori, N.L. Kozyr, Y. Xu, L. Wyatt, P.L. Earl, J.G. Herndon, H.M. McClure, B. Moss, and H.L. Robinson Different patterns of immune responses but similar control of a mucosal immunodeficiency virus challenge by MVA and DNA/MVA vaccines J. Virol. 76 2002 7625 7631
4. D.H. Barouch, S. Santra, J.E. Schmitz, M.J. Kuroda, T.M. Fu, W. Wagner, M. Bilska, A. Craiu, X.X. Zheng, G.R. Krivulka, K. Beaudry, M.A. Lifton, C.E. Nickerson, W.L. Trigona, K. Punt, D.C. Freed, L. Guan, S. Dubey, D. Casimiro, A. Simon, M.E. Davies, M. Chastain, T.B. Strom, R.S. Gelman, D.C. Montefiori, and M.G. Lewis Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination [in process citation] Science 290 5491 2000 486 492
5. D.H. Barouch, S. Santra, M.J. Kuroda, J.E. Schmitz, R. Plishka, A. Buckler-White, A.E. Gaitan, R. Zin, J.H. Nam, L.S. Wyatt, M.A. Lifton, C.E. Nickerson, B. Moss, D.C. Montefiori, V.M. Hirsch, and N.L. Letvin Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination J. Virol. 75 11 2001 5151 5158
6. P.A. Bedford, L.B. Clarke, G.Z. Hastings, and S.C. Knight Primary proliferative responses to peptides of HIV Gag p24 J. Acquired Immune. Defic. Syndr. Hum. Retrovirol. 14 4 1997 301 306
7. M.R. Betts, J. Krowka, C. Santamaria, K. Balsamo, F. Gao, G. Mulundu, C. Luo, N. N'Gandu, H. Sheppard, B.H. Hahn, S. Allen, and J.A. Frelinger Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians J. Virol. 71 11 1997 8908 8911
8. J.N. Blankson, and R.F. Siliciano MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy J. Clin. Invest. 107 5 2001 549 551
9. E. Boritz, B.E. Palmer, B. Livingston, A. Sette, and C.C. Wilson Diverse repertoire of HIV-1 p24-specific, IFN-gamma-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy J. Immunol. 170 2 2003 1106 1116
10. C. Bourgeois, H. Veiga-Fernandes, A.M. Joret, B. Rocha, and C. Tanchot CD8 lethargy in the absence of CD4 help Eur. J. Immunol. 32 8 2002 2199 2207
11. S.J. Brodie, D.A. Lewinsohn, B.K. Patterson, D. Jiyamapa, J. Krieger, L. Corey, P.D. Greenberg, and S.R. Riddell In vivo migration and function of transferred HIV-1-specific cytotoxic T cells Nat. Med. 5 1 1999 34 41
12. H. Cao, P. Kanki, J.L. Sankale, A. Dieng-Sarr, G.P. Mazzara, S.A. Kalams, B. Korber, S. Mboup, and B.D. Walker Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development J. Virol. 71 11 1997 8615 8623
13. H. Cao, I. Mani, R. Vincent, R. Mugerwa, P. Mugyenyi, P. Kanki, J. Ellner, and B.D. Walker Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: relevance to HIV-1 vaccine trials in Uganda J. Infect. Dis. 182 5 2000 1350 1356
14. A.S. De Groot, B. Jesdale, W. Martin, C. Saint Aubin, H. Sbai, A. Bosma, J. Lieberman, G. Skowron, F. Mansourati, and K.H. Mayer Mapping cross-clade HIV-1 vaccine epitopes using a bioinformatics approach Vaccine 21 27-30 2003 4486 4504
15. D.L. Ellenberger, B. Li, L.D. Lupo, S.M. Owen, J. Nkengasong, M.S. Kadio-Morokro, J. Smith, H. Robinson, M. Ackers, A. Greenberg, T. Folks, and S. Butera Generation of a consensus sequence from prevalent and incident HIV-1 infections in West Africa to guide AIDS vaccine development Virology 302 1 2002 155 163
16. G. Ferrari, W. Humphrey, M.J. McElrath, J.-L. Excler, A.-M. Duliege, M.L. Clements, L.C. Corey, D.P. Bolognesi, and K.J. Weinhold Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers Proc. Natl. Acad. Sci. 94 4 1997 1396 1401
17. G. Ferrari, W. Neal, A. Jones, N. Olender, J. Ottinger, R. Ha, M.J. McElrath, P. Goepfert, and K.J. Weinhold CD8 CTL responses in vaccines: emerging patterns of HLA restriction and epitope recognition Immunol. Lett. 79 1-2 2001 37 45
18. N. Frahm, P.J. Goulder, and C. Brander Broad HIV-specific CTL responses reveal extensive HLA class I binding promiscuity of HIV-derived, optimally defined CTL epitopes B. Korber C. Brander B. Haynes R. Koup C. Kuiken J.P. Moore B. Walker D. Watkins HIV molecular immunology 2003rd ed. 2004 Theoretical Biology and Biophysics, Group T-10 Los Alamos, NM 3 ff
19. N. Frahm, B.T. Korber, C.M. Adams, J.J. Szinger, R. Draenert, M.M. Addo, M.E. Feeney, K. Yusim, K. Sango, N.V. Brown, D. SenGupta, A. Piechocka-Trocha, T. Simonis, F.M. Marincola, A.G. Wurcel, D.R. Stone, C.J. Russell, P. Adolf, D. Cohen, T. Roach, A. StJohn, A. Khatri, K. Davis, J. Mullins, P.J. Goulder, B.D. Walker, and C. Brander Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities J. Virol. 78 5 2004 2187 2200
20. Z. Hel, J. Nacsa, E. Tryniszewska, W.P. Tsai, R.W. Parks, D.C. Montefiori, B.K. Felber, J. Tartaglia, G.N. Pavlakis, and G. Franchini Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses J. Immunol. 169 9 2002 4778 4787
21. Y. Ikeda-Moore, H. Tomiyama, K. Miwa, S. Oka, A. Iwamoto, Y. Kaneko, and M. Takiguchi Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1 J. Immunol. 159 12 1997 6242 6252
22. E.M. Janssen, E.E. Lemmens, T. Wolfe, U. Christen, M.G. von Herrath, and S.P. Schoenberger CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes Nature 421 6925 2003 852 856
23. X. Jin, D.E. Bauer, S.E. Tuttleton, S. Lewin, A. Gettie, J. Blanchard, C.E. Irwin, J.T. Safrit, J. Mittler, L. Weinberger, L.G. Kostrikis, L. Zhang, A.S. Perelson, and D.D. Ho Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques J. Exp. Med. 189 6 1999 991 998
24. R.P. Johnson, A. Trocha, L. Yang, G.P. Mazzara, D.L. Panicali, T.M. Buchanan, and B.D. Walker HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells J. Immunol. 147 5 1991 1512 1521
25. S.M. Keating, R.C. Bollinger, T.C. Quinn, J.B. Jackson, and L.M. Carruth Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assays AIDS Res. Hum. Retroviruses 18 14 2002 1067 1079
26. J. Lieberman, J.A. Fabry, D.M. Fong, and G.R. Parkerson III Recognition of a small number of diverse epitopes dominates the cytotoxic T lymphocytes response to HIV type 1 in an infected individual AIDS Res. Hum. Retroviruses 13 5 1997 383 392
27. B. Lotti, T. Wendland, H. Furrer, N. Yawalkar, S. von Greyerz, K. Schnyder, M. Brandes, P. Vernazza, R. Wagner, T. Nguyen, E. Rosenberg, W.J. Pichler, and C. Brander Cytotoxic HIV-1 p55gag-specific CD4+ T cells produce HIV-inhibitory cytokines and chemokines J. Clin. Immunol. 22 5 2002 253 262
28. U. Malhotra, S. Holte, S. Dutta, M.M. Berrey, E. Delpit, D.M. Koelle, A. Sette, L. Corey, and M.J. McElrath Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment J. Clin. Invest. 107 4 2001 505 517
29. K.J. Metzner, X. Jin, F.V. Lee, A. Gettie, D.E. Bauer, M. Di Mascio, A.S. Perelson, P.A. Marx, D.D. Ho, L.G. Kostrikis, and R.I. Connor Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine J. Exp. Med. 191 11 2000 1921 1931
30. L. Musey, Y. Hu, L. Eckert, M. Christensen, T. Karchmer, and M.J. McElrath HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women J. Exp. Med. 185 2 1997 293 303
31. L. Musey, Y. Ding, J. Cao, J. Lee, C. Galloway, A. Yuen, K.R. Jerome, and M.J. McElrath Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes J. Virol. 77 1 2003 291 300
32. P.J. Norris, H.F. Moffett, C. Brander, T.M. Allen, K.M. O'Sullivan, L.A. Cosimi, D.E. Kaufmann, B.D. Walker, and E.S. Rosenberg Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells AIDS Res. Hum. Retroviruses 20 3 2004 315 325
33. H.L. Robinson New hope for an AIDS vaccine Nat. Rev., Immunol. 2 4 2002 239 250
34. E.S. Rosenberg, J.M. Billingsley, A.M. Caliendo, S.L. Boswell, P.E. Sax, S. Kalams, and B.D. Walker Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia Science 278 1997 1447 1450
35. A. Rutebemberwa, B. Auma, J. Gilmour, G. Jones, D. Yirrell, S. Rowland, N. Imami, C. Watera, P. Kaleebu, J. Whitworth, and F. Gotch HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected Ugandans AIDS Res. Hum. Retroviruses 20 7 2004 763 771
36. J.E. Schmitz, M.J. Kuroda, S. Santra, V.G. Sasseville, M.A. Simon, M.A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B.J. Scallon, J. Ghrayeb, M.A. Forman, D.C. Montefiori, E.P. Rieber, N.L. Letvin, and K.A. Reimann Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes Science 283 5403 1999 857 860
37. D.J. Shedlock, and H. Shen Requirement for CD4 T cell help in generating functional CD8 T cell memory Science 300 5617 2003 337 339
38. J.W. Shiver, T. Fu, L. Chen, D. Casimiro, M.E. Davies, R.K. Evans, Z.-Q. Zhang, A. Simon, W.L. Trigona, S. Dubey, L. Huang, V.A. Harris, R.S. Long, L. Xiaoping, L. Handt, W.A. Schleif, L. Zhu, D.C. Freed, N.V. Persaud, L. Guan, K. Punt, A. Tang, M. Chen, K.A. Wilson, K.B. Collins, G.J. Heidecker, H.C. Perry, J.G. Joyce, K.M. Grimm, J.C. Cook, P.M. Keller, D.S. Kresock, H. Mach, R.D. Troutman, L.A. Iospi, D.M. Williams, Z. Xu, K.E. Bohannon, D.B. Volkin, D. Montefiori, A. Miura, G.R. Krivulka, M.A. Lifton, M.J. Kuroda, J.E. Schmitz, N.L. Letvin, M.J. Caulfield, A.J. Bett, R. Youil, D.C. Kaslow, and E.A. Emini Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency virus immunity Nature 415 2002 331 335
39. N.V. Sipsas, S.A. Kalams, A. Trocha, S. He, W.A. Blattner, B.D. Walker, and R.P. Johnson Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1 J. Clin. Invest. 99 4 1997 752 762
40. J.M. Smith, R.R. Amara, H.M. McClure, M. Patel, S. Sharma, H. Yi, L. Chennareddi, J.G. Herndon, S.T. Butera, W. Heneine, D.L. Ellenberger, B. Parekh, P.L. Earl, L.S. Wyatt, B. Moss, and H.L. Robinson Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques AIDS Res. Hum. Retroviruses 20 6 2004 654 665
41. J.M. Smith, R.R. Amara, D. Campbell, Y. Xu, M. Patel, S. Sharma, S.T. Butera, D.L. Ellenberger, H. Yi, L. Chennareddi, J.G. Herndon, L.S. Wyatt, D. Montefiori, B. Moss, H.M. McClure, and H.L. Robinson DNA/MVA vaccine for HIV-1: effects of codon-optimization and the expression of aggregates or virus-like-particles on the immunogenicity of the DNA prime AIDS Res. Hum. Retroviruses 20 2004 1335 1347
42. Smith, J.M., Amara, R.R., Wyatt, L.S., Ellenberger, D.L., Li, B., Herndon, J.G., Patel, M., Sharma, S., Chennareddi, L., Butera, S.T., McNicholl, J.M., McClure, H.M., Moss, B., Robinson, H.L., in press. Studies in macaques on cross-clade T cell responses elicited by a DNA/MVA AIDS vaccine, better conservation of CD8 than CD4 T cell responses. AIDS Res. Hum. Retroviruses.
43. J.C. Sun, and M.J. Bevan Defective CD8 T cell memory following acute infection without CD4 T cell help Science 300 5617 2003 339 342
44. J.C. Sun, M.A. Williams, and M.J. Bevan CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection Nat. Immunol. 5 9 2004 927 933
45. S. Venturini, D.E. Mosier, D.R. Burton, and P. Poignard Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization J. Virol. 76 14 2002 6987 6999
46. C.M. Walker, D.J. Moody, D.P. Stites, and J.A. Levy CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication Science 234 4783 1986 1563 1566
47. C.C. Wilson, B. Palmer, S. Southwood, J. Sidney, Y. Higashimoto, E. Appella, R. Chesnut, A. Sette, and B.D. Livingston Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes J. Virol. 75 9 2001 4195 4207
48. L.S. Wyatt, P.L. Earl, J.Y. Liu, J.M. Smith, D.C. Montefiori, H.L. Robinson, and B. Moss Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component AIDS Res. Hum Retroviruses 20 6 2004 645 653
49. K. Yusim, C. Kesmir, B. Gaschen, M.M. Addo, M. Altfeld, S. Brunak, A. Chigaev, V. Detours, and B.T. Korber Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation J. Virol. 76 17 2002 8757 8768